Efficacy of Shiatsu in Individuals With Fibromyalgia: a Randomized Clinical Trial
Efficacy of Shiatsu in Pain, Flexibility, Sleep, Anxiety and Quality of Life in Individuals With Fibromyalgia: a Randomized Clinical Trial
1 other identifier
interventional
34
1 country
1
Brief Summary
Fibromyalgia is a syndrome characterized by chronic and generalized musculoskeletal pain and tenderness in tender points. Its etiology and physiopathology are not well known; therefore its treatment is not satisfactory. Having this in view, a search for alternative and complementary medicine has been going on. This kind of practice is under pressure to present evidences of efficacy. A randomized clinical trial will be carried out with the aim of verifying the efficacy of a massage technique called Shiatsu in the improvement of pain, flexibility, quality of sleep, anxiety and quality of life of individuals with fibromyalgia. A sample of 34 subjects will be divided in Shiatsu Group and Control Group. All subjects will be evaluated in the beginning, in the middle and at the end of the treatment. Pain will be evaluated by the following instruments: visual analogue scale (VAS) and dolorimetry. The V-sit and reach test (VSRT) will be used to assess the flexibility of the hamstring muscles and lower back. The sleep will be evaluated with the Pittsburgh Sleep Quality Index (PSQI). The State-Trait Anxiety Inventory (STAI) will be used to evaluate anxiety. The evaluation of quality of life will be made with two instruments: fibromyalgia impact questionnaire (FIQ) and Activities-specific Balance Confidence (ABC) scale. In each treatment session, the subjects will be globally evaluated in the 14 main meridians and their respective points by touch, identifying points of excessive energy and their severity. The Control Group will wait for treatment and remain only with conventional pharmacological treatment, while the Shiatsu Group will receive a treatment with Shiatsu during eight weeks. The results will be expressed in mean and standard deviation. The normality of the data will be verified by the Shapiro-Wilk test. In the intragroup analysis, the T-test for the parametric data and the Wilcoxon test for the nonparametric data. In the comparison between groups, the analysis of variance (ANOVA) test will be used. The level of significance adopted will be α \< 0.05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 27, 2011
CompletedFirst Posted
Study publicly available on registry
February 7, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedNovember 15, 2012
November 1, 2012
1.3 years
January 27, 2011
November 14, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in VAS at 8 weeks
In the VAS the subject marks the intensity of its pain in a 10 centimeter horizontal line
baseline and 8 weeks
Secondary Outcomes (13)
Change from baseline in FIQ at 4 weeks
baseline and 4 weeks
Change from baseline in PSQI at 4 weeks
baseline and 4 weeks
Change from baseline in STAI at 4 weeks
baseline and 4 weeks
Change from baseline in VSRT at 4 weeks
baseline and 4 weeks
Change from baseline in FIQ at 8 weeks
baseline and 8 weeks
- +8 more secondary outcomes
Study Arms (2)
Shiatsu Group
EXPERIMENTALControl Group
NO INTERVENTIONInterventions
8-week treatment with two Shiatsu sessions per week (50-minute duration)
Eligibility Criteria
You may qualify if:
- diagnoses of fibromyalgia
You may not qualify if:
- diagnoses of diseases that cause chronic pain
- skin lesions and infection
- pregnancy
- two consecutive absences in treatment sessions
- use of psychotherapy, physiotherapy or complementary therapies in the last 6 months
- regular supervised physical activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Sao Paulo General Hospital
São Paulo, São Paulo, 05403-010, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan LK Yuan, MSc
Faculty of Medicine of the University of Sao Paulo
- STUDY DIRECTOR
Amelia P Marques, PhD
Faculty of Medicine of the University of Sao Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 27, 2011
First Posted
February 7, 2011
Study Start
July 1, 2010
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
November 15, 2012
Record last verified: 2012-11